Paydirt
SS
Insider

Saurabh Saha

Director

Saurabh Saha (Director) filed 13 Form 4 reports in the past 24 months (1 purchase, 12 sales), most often in Centessa Pharmaceuticals plc (CNTA). Across 1 priced purchase filing, the average 21-session return was -8.8% from execution and -3.4% from disclosure (delay-adjusted; derived). The largest single filing was $1.6M of CNTA (87,496 sh × $18.46, as filed), executed Dec 6 2024.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
-8.8%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-3.4%
same 1 filings, from disclosure
Filings, ttm
13
1 buys · 12 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$10.7M
shares × price, as filed
Last traded
Jul 21 2025
Filed Jul 21 2025

Median ADV $76.8M across their filed names

Open performance
Volume by month
$2.6M$1.3M$0Oct 2024Apr 2025Oct 2025Apr 2026Oct 2024 · sells $824KNov 2024 · sells $1.5MDec 2024 · sells $2.6MJan 2025 · sells $841KFeb 2025 · sells $863KMar 2025 · buys $254KMar 2025 · sells $918KApr 2025 · sells $682KMay 2025 · sells $699KJun 2025 · sells $695KJul 2025 · sells $876K
Buys $254K Sells $10.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 12 filings Technology 1 filing

Sector per market data · by filing · past 24 months

Most traded names
CNTA Centessa Pharmaceuticals plc CNTA · 0 buys · 12 sells 12 filings CLVT Clarivate Plc CLVT · 1 buy · 0 sells 1 filing
Recent filings
CNTASALE Centessa Pharmaceuticals plc View filing → $959K
55,000 sh × $17.44
Exec Dec 20 2024
Filed Dec 20 2024 · 5:30 PM ET
CNTASALE Centessa Pharmaceuticals plc View filing → $1.6M
87,496 sh × $18.46
Exec Dec 6 2024
Filed Dec 6 2024 · 5:30 PM ET
CNTASALE Centessa Pharmaceuticals plc View filing → $929K
55,000 sh × $16.89
Exec Nov 20 2024
Filed Nov 22 2024 · 5:30 PM ET
CNTASALE Centessa Pharmaceuticals plc View filing → $585K
32,023 sh × $18.28
Exec Nov 13 2024
Filed Nov 15 2024 · 5:30 PM ET
CNTASALE Centessa Pharmaceuticals plc View filing → $824K
52,408 sh across 2 lots
Exec Oct 21 2024
Filed Oct 23 2024 · 5:30 PM ET
CNTASALE Centessa Pharmaceuticals plc View filing → $909K
55,000 sh × $16.53
Exec Sep 20 2024
Filed Sep 20 2024 · 5:30 PM ET
CNTASALE Centessa Pharmaceuticals plc View filing → $2.9M
175,000 sh × $16.52
Exec Sep 10 2024
Filed Sep 12 2024 · 5:30 PM ET